6Valero C, Garcia Palomo JD, Matorras P, et al. Acinetobacter bacteraemia in a teaching hospital, 1989 -- 1998[J]. Eur J Intern Med, 2001,12 : 425-429.
7Rhomberg PR, Jones RN, MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America[J]. Diagn Microbiol Infect Dis, 2003,47:365-372.
8Pfaller MA, Jones RN, MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase producing En terobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997--2000[J]. Int J Antimicrob Agents,2002,19:383-388.
9Sader HS, Biedenbach DJ, Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48 440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-- 2000) [J]. Diagn Microbiol Infect Dis,2003,47:361-364.
10Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program[J]. Braz J Infect Dis, 2001,5:200-214.
8Hazarik M ,et al. Standantisation of quantitative direct gas Liquid ehr for early detection of bacteria in blood Cultures. Indian J Med Res, 1989,89(2):389.
9Quale J,Landman D,Saurina G, et al. Manipulation of a hospital antimicrobial fomnulary to control an outbreak of vancomycin resistant enterococci. Clin Infect Dis, 1996,23 : 1020.
10Joyce Sutcliffe,Thorsten grebe,et al.Detection of erythromycin-resistant determinants by PCR[J].Antimicrob agents and chemother,1996,40:2562-2566.
